Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

[Efficacy of neoadjuvant chemotherpy in patients with locally advanced gastric cancer].

Wang Y, Liu TS, Zhuang RY, Cui YH, Wang ZM, Yu YY, Hou J, Sun YH, Shen KT, Shen ZB.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Feb;16(2):166-9. Chinese.

PMID:
23446480
2.

Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.

Molina R, Lamarca A, Martínez-Amores B, Gutiérrez A, Blázquez A, López A, Granell J, Álvarez-Mon M.

Eur J Surg Oncol. 2013 Aug;39(8):814-22. doi: 10.1016/j.ejso.2013.05.003. Epub 2013 Jun 5.

PMID:
23755989
3.

Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.

Persiani R, D'Ugo D, Rausei S, Sermoneta D, Barone C, Pozzo C, Ricci R, La Torre G, Picciocchi A.

J Surg Oncol. 2005 Mar 15;89(4):227-36; discussion 237-8.

PMID:
15726615
4.

Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer.

Newman E, Marcus SG, Potmesil M, Sewak S, Yee H, Sorich J, Hayek M, Muggia F, Hochster H.

J Gastrointest Surg. 2002 Mar-Apr;6(2):212-23; discussion 223.

PMID:
11992807
5.

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.

Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y, Katsuki S, Hirayama M, Takahashi M, Ono M, Maeda M, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2013 Mar;71(3):789-97. doi: 10.1007/s00280-013-2073-5. Epub 2013 Jan 22.

PMID:
23338051
6.

Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.

Barone C, Cassano A, Pozzo C, D'Ugo D, Schinzari G, Persiani R, Basso M, Brunetti IM, Longo R, Picciocchi A.

Oncology. 2004;67(1):48-53.

PMID:
15459495
7.

A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.

Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP.

Ann Oncol. 2006 Sep;17(9):1404-11. Epub 2006 Jun 20.

8.

[Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer].

Li T, Chen L.

Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Feb;14(2):104-6. Chinese.

PMID:
21365500
9.

[Neoadjuvant chemotherapy for locally advanced gastric cancer].

Kalmár K, Cseke L, Káposztás Z, Horváth G, Varga E.

Magy Seb. 2003 Oct;56(5):177-84. Hungarian.

PMID:
15022621
10.

Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?

Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gonen M, Kelsen DP, Brennan MF, Coit DG.

Ann Surg Oncol. 2007 Dec;14(12):3412-8. Epub 2007 Oct 2.

PMID:
17909917
11.

Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer.

Tsuburaya A, Nagata N, Cho H, Hirabayashi N, Kobayashi M, Kojima H, Munakata Y, Fukushima R, Kameda Y, Shimoda T, Oba K, Sakamoto J.

Cancer Chemother Pharmacol. 2013 May;71(5):1309-14. doi: 10.1007/s00280-013-2130-0. Epub 2013 Mar 5.

PMID:
23463482
12.

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, Haag C, Mauer ME, Hasan B, Welch J, Ott K, Hoelscher A, Schneider PM, Bechstein W, Wilke H, Lutz MP, Nordlinger B, Van Cutsem E, Siewert JR, Schlag PM.

J Clin Oncol. 2010 Dec 10;28(35):5210-8. doi: 10.1200/JCO.2009.26.6114. Epub 2010 Nov 8.

13.

Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.

Yano M, Shiozaki H, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Tsujinaka T, Monden M.

World J Surg. 2002 Sep;26(9):1155-9. Epub 2002 Jun 24.

PMID:
12209246
14.
15.

Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study.

Newman E, Potmesil M, Ryan T, Marcus S, Hiotis S, Yee H, Norwood B, Wendell M, Muggia F, Hochster H.

Semin Oncol. 2005 Dec;32(6 Suppl 9):S97-100.

PMID:
16399443
16.

Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.

Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H.

Eur J Surg Oncol. 2012 Feb;38(2):143-9. doi: 10.1016/j.ejso.2011.11.009. Epub 2011 Dec 9.

PMID:
22154885
17.

Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.

Kochi M, Fujii M, Kanamori N, Kaiga T, Takahashi T, Kobayashi M, Takayama T.

J Cancer Res Clin Oncol. 2006 Dec;132(12):781-5. Epub 2006 Jun 28.

PMID:
16804723
18.

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.

Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.

Cancer J Sci Am. 1998 Mar-Apr;4(2):125-31.

PMID:
9554929
19.

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.

Jin H, Zhang G, Liu X, Liu X, Chen C, Yu H, Huang X, Zhang Q, Yu J.

World J Surg Oncol. 2013 May 24;11:112. doi: 10.1186/1477-7819-11-112.

20.

Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.

Becker K, Langer R, Reim D, Novotny A, Meyer zum Buschenfelde C, Engel J, Friess H, Hofler H.

Ann Surg. 2011 May;253(5):934-9. doi: 10.1097/SLA.0b013e318216f449.

PMID:
21490451
Items per page

Supplemental Content

Write to the Help Desk